checkAd

    Waters - jetzt einsteigen? - 500 Beiträge pro Seite

    eröffnet am 19.06.01 16:53:04 von
    neuester Beitrag 24.07.01 16:21:51 von
    Beiträge: 2
    ID: 423.419
    Aufrufe heute: 0
    Gesamt: 383
    Aktive User: 0


     Durchsuchen

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 19.06.01 16:53:04
      Beitrag Nr. 1 ()
      Monday June 18, 5:00 pm Eastern Time
      Press Release
      Waters Corporation Updates Second Quarter 2001 Earnings Outlook
      MILFORD, Mass.--(BUSINESS WIRE)--June 18, 2001--Waters Corporation (NYSE:WAT - news) updated its earnings outlook for the second quarter of 2001 today. The Company last addressed its expectations during its April 27, 2001 conference call held to discuss first quarter 2001 financial results. Estimates for the second quarter of 2001 at that time were for sales growth before currency effects of between 14% and 16% compared to the second quarter of 2000, sales growth of between 10% and 12% after currency effects, and earnings per diluted share of $0.33, subject to normal tolerances of $0.01 to $0.02.

      It now appears that sales growth will be slower and, therefore, earnings lower for the second quarter of 2001. This slower sales growth largely relates to the Company`s mass spectrometry product line. Douglas A. Berthiaume, Chairman and Chief Executive Officer, said: ``Following a sustained period of dramatic growth, the Company`s mass spectrometry business is currently experiencing a slowdown in sales. This slowdown is believed to be attributed partially to delayed purchases within large pharmaceutical customer accounts deciding between a multitude of new products recently introduced by the Company and its competitors.`` For the second quarter of 2001, possible sales growth before currency effects is now estimated between 7% and 10%, sales growth after currency effects is estimated between 2% and 5% (assuming that today`s exchange rates remain unchanged through quarter end), and earnings per diluted share are estimated at $0.29, subject to normal tolerances of $0.01 to $0.02.

      The Company`s ability to estimate results for the second half of 2001 is somewhat limited currently. The Company plans to provide information regarding the second half in conjunction with its second quarter 2001 earnings release scheduled for July 24, 2001.

      The Company will webcast its conference call to discuss this update on Tuesday, June 19, 2001, at 8:00 a.m. eastern time. To listen to the call, connect to www.waters.com and access the investor relations section. A replay will be available through June 22, 2001 similarly by webcast, and also by phone at 402-998-1479.

      CAUTIONARY STATEMENT

      Most statements contained herein are forward looking. All such statements reflect only current expectations and actual results may differ materially. The Company does not obligate or commit itself, by providing the guidance above, to update predictions. Many factors could cause results to differ from these statements, including actual results for the balance of the quarter, loss of market share through competition, introduction of competing products by other companies, changes in the healthcare market and the pharmaceutical industry, changes in distribution of the Company`s products and foreign exchange fluctuations. Many of these factors are discussed in detail in the Company`s Securities and Exchange Commission filings.

      ABOUT WATERS CORPORATION

      Waters Corporation holds worldwide leading positions in three complementary analytical technologies--high performance liquid chromatography, mass spectrometry and thermal analysis--which account for $4 billion in annual revenues of the $18 billion analytical instrument industry total.

      -------------

      Ein etwas heftiger Abschlag für diese Nachricht. Noch hab ich Waters nur auf der Watchlist und nicht im Depot. Hat jemand weiterführende Infos aus der Brache?

      Vielen Dank vorab für Rückmeldungen.

      Gruß
      @sse
      Avatar
      schrieb am 24.07.01 16:21:51
      Beitrag Nr. 2 ()
      ---------------

      Waters up after meeting lowered Q2 net (WAT) By Michael Baron
      Waters Corp. (WAT) is adding $2.88, or 11.3 percent, to $28.27, after the Milford, Mass., analytical technology firm reported second-quarter earnings of $39.3 million, or 29 cents a share, up from a year-ago profit of $38.4 million, or 28 cents a share, and in line with lowered Wall Street expectations. Sales rose in the latest three months to $206.8 million from $197.4 million in the same period a year earlier. "Although second quarter results didn`t achieve our original expectations, our profitability and financial position remain substantial, and we are optimistic about our future business prospects," said Douglas Berthiaume, the company`s chairman and CEO, in a press release. "We anticipate steady improvement in sales growth rates and profitability going forward."

      ---------------

      Waters Corporation Second Quarter 2001 Sales Up 9% Before Currency Effects, Earnings Per Diluted Share Up 4%
      TUESDAY, JULY 24, 2001 7:00 AM
      - BusinessWire

      MILFORD, Mass., Jul 24, 2001 (BUSINESS WIRE) -- Waters Corporation (NYSE:WAT) reported today that second quarter 2001 sales increased by 9% over prior year levels before unfavorable currency effects. After currency effects, reported sales growth was 5%. Earnings per diluted share (E.P.S.) were $0.29 for the quarter, representing a 4% increase over prior year E.P.S. of $0.28.

      Douglas A. Berthiaume, Chairman and Chief Executive Officer, said: "Consistent with our mid-June update, second quarter sales growth slowed from recent historical levels principally in our mass spectrometry product line. Demand for our quadrupole time-of-flight mass spectrometry products grew very strongly during the quarter, reflecting expanding interest from proteomics customers. However sales of our triple quadrupole products were flat and sales of other mass spectrometry products declined, resulting from both difficult prior year comparisons and slowed customer purchase decisions, particularly within large pharmaceutical accounts. Our HPLC product line continued to perform well with growth in the low double digits. Thermal analysis sales were down slightly as the industrial chemical customer base for this product line continued to be weak. Although second quarter results didn`t achieve our original expectations, our profitability and financial position remain substantial, and we are optimistic about our future business prospects. We anticipate steady improvement in sales growth rates and profitability going forward."

      As communicated in a prior press release, Waters Corporation will webcast its second quarter 2001 financial results conference call this morning, July 24, 2001, at 8:30 a.m. eastern time. To listen to the call, connect to www.waters.com and access the investor relations section. A replay of the call will be available from today through July 30, 2001 similarly by webcast, and also by phone at 402-998-0680.

      Waters Corporation holds worldwide leading positions in three complementary analytical technologies - high performance liquid chromatography, thermal analysis and mass spectrometry - which account for $4 billion in annual revenues of the $18 billion analytical instrument industry total.

      CAUTIONARY STATEMENT
      Certain statements contained herein are forward looking. Many factors could cause actual results to differ from these statements, including loss of market share through competition, introduction of competing products by other companies, pressures on prices from competitors and/or customers, regulatory obstacles to new product introductions, lack of acceptance of new products, changes in the healthcare market and the pharmaceutical industry, changes in distribution of the Company`s products, and foreign exchange fluctuations. Such factors are discussed in detail in the Company`s filings with the Securities and Exchange Commission.

      Waters Corporation and Subsidiaries
      Consolidated Statements of Operations
      (In thousands, except per share data)
      (Unaudited)

      Three Months Ended Six Months Ended
      June 30 June 30
      2001 2000 2001 2000

      Net sales 206,803 197,408 407,835 377,610
      Cost of sales 75,545 71,777 148,843 138,117

      Gross profit 131,258 125,631 258,992 239,493

      Selling, general
      and administrative
      expenses 67,169 61,060 133,076 121,455
      Research and
      development
      expenses 11,741 10,557 22,779 20,919
      Goodwill and
      purchased technology
      amortization 1,771 1,760 3,519 3,571

      Operating income 50,577 52,254 99,618 93,548

      Interest income
      (expense), net 1,151 (343) 2,637 (1,044)
      Income before
      income taxes 51,728 51,911 102,255 92,504

      Provision for
      income taxes 12,415 13,506 24,542 24,051
      Income before
      cumulative
      effect of
      change in
      accounting
      principle 39,313 38,405 77,713 68,453

      Cumulative effect of
      change in accounting
      principle (A) -- -- -- (10,771)
      Net income 39,313 38,405 77,713 57,682

      Income per basic
      common share:
      Net income before
      cumulative effect
      of accounting
      principle change 0.30 0.30 0.60 0.54
      Cumulative effect
      of change in
      accounting
      principle (A) -- -- -- (0.09)
      Net income 0.30 0.30 0.60 0.45

      Income per diluted
      common share:
      Net income before
      cumulative effect
      of accounting
      principle change 0.29 0.28 0.56 0.50
      Cumulative effect
      of change in
      accounting
      principle (A) -- -- -- (0.08)
      Net income 0.29 0.28 0.56 0.42

      Weighted average
      number of basic
      common shares 130,564 126,914 130,363 126,246

      Weighted average
      number of diluted
      common shares
      and equivalents 137,564 136,222 137,785 135,720


      (A) Effect at January 1, 2000 of adopting Securities and Exchange
      Commission Staff Accounting Bulletin #101, recorded in first
      quarter 2000






      Waters Corporation and Subsidiaries
      Condensed Consolidated Balance Sheets
      (In Thousands)

      June 30, December 31,
      2001 2000
      (Unaudited)

      Cash and cash equivalents 134,514 75,509
      Accounts receivable 162,315 167,713
      Inventories 107,478 87,275
      Other current assets 16,862 13,299
      Total current assets 421,169 343,796

      Property, plant and equipment, net 109,873 102,608
      Other assets 245,080 245,941
      Total assets 776,122 692,345

      Notes payable 2,179 4,879
      Accounts payable and accrued expenses 226,264 215,654
      Total current liabilities 228,443 220,533

      Other liabilities 19,905 20,031
      Total liabilities 248,348 240,564

      Total equity 527,774 451,781
      Total liabilities and equity 776,122 692,345

      CONTACT: Waters Corporation
      Brian Mazar, Vice President of Investor Relations
      508-482-2193

      URL: http://www.businesswire.com
      Today`s News On The Net - Business Wire`s full file on the Internet
      with Hyperlinks to your home page.

      Copyright (C) 2001 Business Wire. All rights reserved.

      KEYWORD: MASSACHUSETTS
      INDUSTRY KEYWORD: COMPUTERS/ELECTRONICS
      EARNINGS


      Beitrag zu dieser Diskussion schreiben


      Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
      Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie
      hier
      eine neue Diskussion.

      Investoren beobachten auch:

      WertpapierPerf. %
      +0,88
      +0,61
      +0,68
      -0,50
      +3,33
      -1,50
      +3,72
      +0,58
      +1,57
      +0,13
      Waters - jetzt einsteigen?